Difficulties of Managing Submassive and Massive Pulmonary Embolism in the Era of COVID-19 - ScienceDirect
JKMS :: Journal of Korean Medical Science
Percutaneous treatment options for acute pulmonary embolism: a clinical consensus statement by the ESC Working Group on Pulmonary Circulation and Right Ventricular Function and the European Association of Percutaneous Cardiovascular Interventions -
Treatment of Submassive Pulmonary Embolism (PE): Full Dose, Half Dose, or No Dose? - REBEL EM - Emergency Medicine Blog
32028-3.fp.png "COMPARISON OF ALTEPLASE DOSING STRATEGIES IN PATIENTS UNDERGOING CATHETER DIRECTED THROMBOLYSIS FOR ACUTE PULMONARY EMBOLISM | Journal of the American College of Cardiology")
COMPARISON OF ALTEPLASE DOSING STRATEGIES IN PATIENTS UNDERGOING CATHETER DIRECTED THROMBOLYSIS FOR ACUTE PULMONARY EMBOLISM | Journal of the American College of Cardiology
Thrombolytic Therapy During Cardiac Arrest for Suspected Massive Pulmonary Embolism Guideline
Submassive & Massive PE - EMCrit Project
Risk Factors Associated with Bleeding After Alteplase Administration for Pulmonary Embolism: A Case‐Control Study - Curtis - 2014 - Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy - Wiley Online Library
Massive Pulmonary Thromboembolism and Thrombolytics - Manual of Medicine
Hemodynamic Effects of Ultrasound-Assisted, Catheter-Directed, Very Low-Dose, Short-Time Duration Thrombolysis in Acute Intermediate–High Risk Pulmonary Embolism (from the EKOS-PL Study) - ScienceDirect
The Safe and Appropriate Use of Thrombolytics in the Emergency Department
Efficacy of thrombolytic agents in the treatment of pulmonary embolism | European Respiratory Society
British Thoracic Society guidelines for the management of suspected acute pulmonary embolism | Thorax
肺栓塞 PULMONARY EMBOLISM 抗凝血劑劑量 HEPARIN DOSAGE @ 急診小醫師 :: 隨意窩 Xuite日誌
Dosing & Administration Guidelines for Activase® (alteplase)
EMNote.org - EMNote
Low-Dose Systemic Alteplase (tPA) for the Treatment of Pulmonary Embolism | Semantic Scholar
Tenecteplase versus alteplase for the management of acute ischaemic stroke in Norway (NOR-TEST 2, part A): a phase 3, randomised, open-label, blinded endpoint, non-inferiority trial - The Lancet Neurology
Actilyse Full Prescribing Information, Dosage & Side Effects | MIMS Philippines
Deep Venous Thrombosis: The “Economy Class Syndrome”
Frontiers | Tenecteplase in Pulmonary Embolism Patients: A Meta-Analysis and Systematic Review
PulmCrit- Submassive PE 2017: Getting 'em off the cliff
Pulmonary Embolism Treatment Systemic Thrombolysis ... | GrepMed
Submassive & Massive PE - EMCrit Project
Thrombolytics for PE in Cardiac Arrest – CriticalCareNow
Table 2 from Comparative efficacy of a two-hour regimen of streptokinase versus alteplase in acute massive pulmonary embolism: immediate clinical and hemodynamic outcome and one-year follow-up. | Semantic Scholar
